Hemodynamic Tolerability Map for Anti-Tachyarrhythmia Therapy Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cardiac rhythm management systems face challenges in determining the necessity of anti-tachyarrhythmia therapy delivery, as they rely on the type and origin of tachyarrhythmia rather than the patient's individual hemodynamic tolerability, leading to potential unnecessary or delayed therapy.
Innovation Solution
A CRM system that includes a hemodynamic tolerability analyzer and control circuit to generate a hemodynamic tolerability map by inducing varying degrees of tachyarrhythmia through pacing pulses, monitoring associated symptoms, and correlating hemodynamic parameters with tolerability levels, thereby determining the appropriateness of anti-tachyarrhythmia therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If anti-tachyarrhythmia therapy is delivered based solely on tachyarrhythmia type and origin, then therapy delivery is simplified, but treatment accuracy and appropriateness deteriorate
Solution Approach 1:
The system transitions from binary therapy decisions (deliver or withhold) based on arrhythmia type to a continuous decision-making framework using multiple hemodynamic parameters. By measuring parameters like stroke volume, cardiac output, and blood pressure changes, the system creates a spectrum of hemodynamic tolerability that enables nuanced therapy selection, resolving the contradiction between simple decision-making and accurate treatment determination.
Solution Approach 2:
Hemodynamic parameters serve as an intermediary between the detected arrhythmia and the therapy decision. Instead of directly linking arrhythmia type to therapy delivery, the system introduces hemodynamic tolerability as a mediating factor that translates physiological state into clinical decision-making, thereby improving treatment accuracy without overly complicating the operational process.
2Measurement precision
If hemodynamic monitoring is implemented to determine therapy necessity, then therapy appropriateness improves, but device complexity increases
Solution Approach 1:
The system leverages existing hemodynamic monitoring capabilities already present in many ICDs for dual purposes: traditional arrhythmia management and now hemodynamic tolerability assessment. By making the monitoring system multi-functional, the patent improves therapy appropriateness determination without proportionally increasing device complexity, as the same infrastructure serves multiple clinical objectives.
Solution Approach 2:
The system uses the patient's own hemodynamic response to the arrhythmia and pacing maneuvers as the basis for therapy decision-making. By leveraging the patient's physiological data rather than requiring external monitoring equipment or complex additional sensors, the system achieves accurate hemodynamic assessment while minimizing increases in device complexity.
3Measurement precision
If therapy delivery is delayed to assess hemodynamic tolerability, then treatment accuracy improves, but response time deteriorates
Solution Approach 1:
The system performs preliminary hemodynamic assessment during or immediately after the arrhythmia episode using brief pacing maneuvers. By conducting this assessment in advance or at the critical moment rather than after therapy delivery, the system maintains rapid response time while still achieving accurate determination of therapy necessity through pre-positioned physiological data collection.
Solution Approach 2:
The system implements periodic, brief hemodynamic assessment intervals rather than continuous monitoring during all arrhythmia episodes. By spacing out the monitoring actions in a periodic manner, the system reduces the time burden on each individual assessment while maintaining overall treatment accuracy, allowing rapid response when needed without the overhead of constant evaluation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for personalized and timely delivery of anti-tachyarrhythmia therapy based on individual patient tolerability, reducing unnecessary treatments and ensuring timely intervention during life-threatening conditions.
Implementation Method 1
An ICD is a CRM device that delivers cardioversion/defibrillation pulses, each being an electric shock, to terminate a detected tachyarrhythmia episode by depolarizing the entire myocardium simultaneously
Implementation Method 2
ICD is a CRM device that delivers cardioversion/defibrillation pulses, each being an electric shock, to terminate a detected tachyarrhythmia episode by depolarizing the entire myocardium simultaneously
Data Source
AI summary
A cardiac rhythm management system identifies a relationship between one or more hemodynamic parameters sensed from a patient and levels of hemodynamic tolerability of the patient. The identified relationship allows an implantable medical device to control delivery of anti-tachyarrhythmia therapy using the patient's hemodynamic tolerability during a detected tachyarrhythmia episode, in addition to classifying the detected tachyarrhythmia episode by its type and origin.